Prevalence and Distribution of Unexpected Actionable Germline Pathogenic Variants Identified on Broad-Based Multigene Panel Testing Among Patients With Cancer The National Cancer Institute-Molecular ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc. (Arima), a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, ...

Scientists in the laboratory of Rendong Yang, Ph.D., associate professor of Urology, have developed a new large language model that can interpret transcriptomic data in cancer cell lines more ...

Access to and Timeliness of Lung Cancer Surgery, Radiation Therapy, and Systemic Therapy in New Zealand: A Universal Health Care Context Gene fusions are critical oncogenic mutations that drive cancer ...

BOSTON--(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced a collaboration to develop Foundation Medicine’s RNA platform as a companion diagnostic for Merus N.V.’s (Nasdaq: MRUS) bispecific ...

SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics (BNGO), Inc. today announced the publication of a study from Penn State College of Medicine that used optical genome mapping (OGM) to ...

SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced the publication of a study in Cancers from The University of Texas MD Anderson Cancer Center showing how ...

Although there are striking differences between the cells that make up your eyes, kidneys, brain and toes, the DNA blueprint ...

They found that DNA sequencing and ctDNA testing detected NUT fusions less than 25 percent of the time. In contrast, NUT IHC, RNA fusion testing, and NUTM1 FISH testing detected NUT carcinoma fusions ...